Developer docs
API playgroundTry for free, no card

Search company profiles

Kwang Dong Pharmaceutical

Full company profile

uuid003dadz

Namestring
Kwang Dong Pharmaceutical
Legal namestring
Kwang Dong Pharmaceutical Co., Ltd.
Websiteurl
ekdp.com
Company typeenum
Public
Founded yearint
1963
Descriptiontext

Kwang Dong Pharmaceutical (광동제약) is a South Korean pharmaceutical and consumer health company headquartered in Gwangmyeong-si, Gyeonggi-do, founded in 1963. The company operates across four primary revenue streams: ethical/prescription pharmaceuticals (including diabetes medications such as 다콤시타정 and 피오맥스정), over-the-counter general pharmaceuticals (including the founding product 경옥고/Kyung-ok-go and 아이톡 eye drops), health functional foods (vitamins, supplements, and ginseng-based products), and general distribution beverages and foods (Vita500, Sunkist-licensed drinks, 옥수수수염차, 헛개차). Its flagship consumer brand, 비타500 (Vita500), launched in 2001 as Korea's first vitamin C-containing drink, has cumulatively surpassed 25 billion bottles sold by 2010 and reached a run-rate of 40 million bottles per month by 2012.

The company's product portfolio is anchored in traditional Korean herbal medicine formulations documented in the 17th-century classical text Donguibogam (동의보감), combined with modern pharmaceutical and beverage manufacturing under HACCP and GMP dual certification. Its founding product, 경옥고 (Kyung-ok-go), is a herbal tonic made from ginseng, poria, raw rehmannia, and honey, slow-cooked at 98°C for 120 hours, and is sold exclusively through pharmacies as a licensed general pharmaceutical. Vita500 and its derivatives (Vita500 ZERO, ZERO Sparkling, Kids, Sports C, ACE, Gold) provide differentiated vitamin C delivery formats. The company holds Korean Patent No. 10-2020-0069921 for a composite antler-angelica gigas extract used in 노녹용전력선보감, marketed as Korea's first and only antler-based health functional food as of November 2024. ISMS information security certification covers external service channels through April 2027.

Kwang Dong runs a hybrid B2C/B2B distribution model with channels tailored to product category: prescription ethical drugs and 경옥고 through pharmacy networks nationwide; general distribution beverages (Vita500, Sunkist, 옥수수수염차) through convenience stores and supermarkets; and direct-to-consumer sales through three company-operated e-commerce platforms—광동상회 (kwangdongmart.com), KD케어몰 (kdcaremall.com), and 광동약국몰 (kdshop.co.kr). Marketing relies on mass media (TV, radio, print), celebrity endorsements (Karina, Jeon So-mi, Baek Jong-won, Yu Hae-jin), and social media. The company is publicly listed with a dual co-CEO governance structure introduced in March 2026 (Choi Seong-won as Vision CEO, Park Sang-young as Management CEO) and wholly-owned subsidiaries spanning e-commerce (Kwangdong Mart, KD Care Mall), health bio (Kwang Dong Health Bio), and distribution (Kwang Dong Life Health).

Short descriptiontext

Kwang Dong Pharmaceutical is a South Korean pharmaceutical company founded in 1963 that manufactures traditional herbal tonics, prescription drugs, OTC medicines, health functional foods, and consumer beverages (notably Vita500), distributing them through pharmacies, convenience stores, supermarkets, and proprietary e-commerce platforms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
consumer pharmaceuticals, Korean herbal medicine, vitamin C beverages, health functional foods, OTC medicines
Industry4 codes
PRIMARYCRADAHAN
Powdered & Instant Beverage Mixes (Drink Mixes, Instant Coffee/Tea, Electrolytes)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Non-Alcoholic Beverages (Coffee, Tea, Soft Drinks, Water)
SECONDARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYCRAOAHAG
Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience)
NAICS code4 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Medicinal Chemicals & Botanical Products2833
Product category
Consumer Pharmaceuticals and Health Functional Foods
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Ethical/Prescription Pharmaceuticals
TypeOne Time License
Description

Prescription drugs requiring physician prescriptions, including medications for diabetes (경구용 혈당강하제), cardiovascular conditions, and other therapeutic categories.

ekdp.com:443
2General Pharmaceuticals (OTC)
TypeOne Time License
Description

Over-the-counter medicines sold directly to consumers through pharmacies, including products like 경옥고, 아이톡 eye drops, and various cold/flu remedies.

ekdp.com:443
3Health Functional Foods
TypeOne Time License
Description

Products with functional health claims including vitamins, supplements, and ginseng-based products regulated under Korea's Health Functional Food Act.

ekdp.com:443
4General Distribution Foods
TypeOne Time License
Description

Beverages and food products distributed through convenience stores, supermarkets, and general retail channels. Includes 비타500, 썬키스트, traditional herbal beverages, and various drink products.

ekdp.com:443
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1비타500 (Vita500)
Description

Healthy vitamin C drink containing 500mg of vitamin C, the company's flagship consumer health beverage.

ekdp.com
+6 more records
Core offering1 text field

Kwang Dong Pharmaceutical manufactures and sells a diversified portfolio of prescription pharmaceuticals, OTC medicines, health functional foods, traditional Korean herbal tonics, and consumer beverages under brands such as Vita500 (비타500), Kyung-ok-go (경옥고), Sunkist, Corn silk tea, Hutgae-cha, Carmex, and Gongjindan. The company operates HACCP- and GMP-certified production facilities and distributes products through pharmacies, convenience stores, supermarkets, and company-owned e-commerce platforms (kwangdongmart.com, kdcaremall.com, kdshop.co.kr) primarily in South Korea with select export to Japan.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Liquid vitamin C absorption is approximately 2x higher than capsule or tablet forms based on clinical study (Journal of Food Science, 2022)
+1 more record
Product overview1 text field

Kwang Dong Pharmaceutical is a comprehensive pharmaceutical and health products company offering a diverse portfolio organized into: general pharmaceuticals (일반의약품), prescription drugs (전문의약품), raw material pharmaceuticals, quasi-drugs, pharmacy drinks, general food products, health functional foods, and traditional Korean herbal products. Key brands include 비타500 (flagship vitamin C drink launched 2001, Korea's first vitamin drink), 경옥고 (founding product since 1963, traditional herbal tonic), 헛개차, 옥수수수염차, 광동초이스 ( 쌍화진 series), 카멕스 (lip care), 썬키스트 (citrus beverages), 레돌민 (sleep aid), and various health supplements. The company also offers prescription medications for diabetes treatment (다콤시타정, 디아리드정, 피오맥스정). The portfolio spans from traditional Korean medicine to modern functional beverages and health supplements, addressing various health needs from fatigue recovery to immune support.

Product and service17 records
1Vita500 (비타500)
CategoryVitamin C Functional Beverages
Description

Korea's first vitamin-containing drink containing 500mg of vitamin C; the flagship consumer health beverage available in multiple variants. Targets health-conscious consumers, students, and general public seeking daily vitamin C intake and energy support.

2Kyung-ok-go (경옥고)
CategoryTraditional Korean Herbal Medicine
Description

Traditional Korean herbal tonic (일반의약품) based on a prescription from Donguibogam; made by simmering ginseng, poria, raw rehmannia, and honey for 120 hours (5 days). Targets health-conscious consumers seeking fatigue recovery, vitality, and traditional wellness support. Sold in stick pack format since 2016.

3Vita500 ZERO (비타500 ZERO)
CategoryVitamin C Functional Beverages
Description

Zero-sugar, zero-calorie version of Vita500 containing 500mg vitamin C. Targets consumers seeking sugar-free vitamin supplementation.

4Vita500 ZERO Sparkling (비타500 ZERO 스파클링)
CategoryVitamin C Functional Beverages
Description

Sparkling water version of Vita500 ZERO launched in 2024. Targets consumers seeking carbonated, zero-sugar vitamin C beverages.

5Corn Silk Tea (옥수수수염차)
CategoryGeneral Distribution Foods (Herbal Beverages)
Description

Traditional herbal tea product for health maintenance. Distributed through convenience stores, supermarkets, and company e-commerce channels.

6Hutgae-cha (헛개차)
CategoryGeneral Distribution Foods (Herbal Beverages)
Description

Traditional herbal tea made from Houttuynia cordata; distributed through convenience stores and supermarkets.

7Sunkist (썬키스트)
CategoryGeneral Distribution Foods (Soft Beverages)
Description

Licensed Sunkist brand beverage products including Sunkist Orange Soda and Sunkist Coco (coconut jelly drink). Distributed through convenience stores and supermarkets.

8Carmex (카멕스)
CategoryLip Care / OTC Skincare
Description

Lip balm and lip care products; consumer personal care offering for everyday lip moisture and protection.

9Eyetok (아이톡)
CategoryGeneral OTC Pharmaceuticals (Ophthalmics)
Description

Eye drop products including 아이톡점안액 (Eyetok trehalose-hydrate eye drops) for eye moisture and lubrication. Sold through pharmacies as OTC general pharmaceutical.

10Redormin (레돌민)
CategoryGeneral OTC Pharmaceuticals (Sedatives)
Description

Sleep aid product (general pharmaceutical, sedative class). Sold through pharmacies. Targets consumers with sleep difficulties.

11Gongjindan (공진단)
CategoryGeneral OTC Pharmaceuticals (Tonic)
Description

Traditional Korean medicine tonic (general pharmaceutical, tonic/restorative class). Sold through pharmacies for vitality and recovery.

12Kwangdong Chimhwan (광동 침향환)
CategoryTraditional Korean Material Foods
Description

Traditional herbal pill (환/丸) containing aromatic resin (침향), honey, deer antler, and various Korean medicinal herbs. Classified as traditional material food (전통소재식품).

13Kwangdong Health Functional Foods Line
CategoryHealth Functional Foods
Description

Health functional foods including Kwangdong Multi Vitamin Mineral, Kwangdong Eye Health Lutein, Kwangdong Green Propolis, Kwangdong Lutein Calcium, Kwangdong Bright 365 Red Ginseng, and antler-based products (including patented 녹용전립선보감). Sold through pharmacies and retail channels.

14Kwangdong General Pharmaceuticals Line
CategoryGeneral OTC Pharmaceuticals
Description

General OTC pharmaceuticals including Kwangdong Ssanghwatang, Kwangdong Wonhwatang, Kwangdong Uhwangcheongsimwon, Multi Capsule F, Hadicof-F, and various vitamins and digestive aids. Sold through pharmacies.

15Kwangdong Prescription Pharmaceuticals Line
CategoryPrescription Pharmaceuticals (Diabetes)
Description

Prescription pharmaceuticals (전문의약품) including 다콤시타정, 디아리드정, 자누로디정, and 피오맥스정 for diabetes treatment. Sold through pharmacies upon physician prescription.

16Vita500 Kids (비타500 키즈)
CategoryVitamin C Functional Beverages
Description

Product line extension of Vita500 formulated for children; vitamin C beverage for pediatric consumers.

17Vita500 Sports C (비타500 스포츠 C)
CategoryVitamin C Functional Beverages
Description

Product line extension of Vita500 formulated for athletes and active individuals; vitamin C beverage for sports/recovery use.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Precision Bio (프리시전바이오)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Kwang Dong Pharmaceutical participated in Precision Bio's capital increase in October 2025, indicating a strategic investment in the biotechnology sector. This aligns with the company's expansion into precision medicine and advanced healthcare solutions.

ekdp.com
2Kwang Dong Health Bio (광동헬스바이오)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Kwang Dong Pharmaceutical participates in Kwang Dong Health Bio's capital increases and provides funding support, indicating this subsidiary is a core part of the company's health and biotechnology strategy. Products like 녹용전립선보감 are manufactured at the Kwang Dong Health Bio factory.

ekdp.com
3Kwang Dong Life Health (광동생활건강)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Family company handling distribution and sales of health and lifestyle products. Listed as the seller/distributor for various health functional foods and beauty products. Approved for concurrent representation as CEO of the company.

ekdp.com:443
4Kwang Dong Hospital (광동병원)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Family company hospital operation, part of the Kwang Dong group ecosystem. Serves as a related business entity within the corporate family.

ekdp.com:443
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

B2B e-commerce platform (koreab2b.com) operated by the company for business-to-business product distribution.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
1Bayer Consumer Health
TypeBroad incumbent
Description

Bayer Consumer Health produces global vitamin and supplement brands (Redoxon, Berocca, Supradyn) that overlap with Kwang Dong's vitamin C drink and health functional food portfolio. Broad incumbent in the same OTC vitamin category with multinational scale advantages.

TypeDirect peer
Description

Dong-A Pharmaceutical is a major Korean pharmaceutical company with both prescription drugs (e.g., Stillen) and OTC consumer health brands (e.g., Bacchus, Wonmi). It directly competes with Kwang Dong across OTC and consumer beverage categories in the Korean market.

3Korea Ginseng Corporation
TypeDirect peer
Description

Korea Ginseng Corporation (KGC) is the state-affiliated producer of Cheong-Kwan-Jang red ginseng products, directly competing with Kwang Dong's herbal tonic (Kyung-ok-go) and ginseng-based health functional foods in the Korean traditional wellness category.

TypeDirect peer
Description

Yuhan Corporation is a major Korean pharmaceutical and consumer health company producing prescription drugs and OTC products. Comparable to Kwang Dong in scale, listed-company structure, and diversified pharma/consumer health portfolio.

5Binggrae
TypeDirect peer
Description

Binggrae is a major Korean food and beverage company producing mass-market drinks and snacks distributed through Korean convenience stores and supermarkets. Directly comparable to Kwang Dong's general distribution foods and Vita500/Sunkist beverage portfolio in retail channels.

6Ildong Pharmaceutical
TypeDirect peer
Description

Ildong Pharmaceutical is a Korean pharmaceutical company with a portfolio spanning prescription drugs, OTC, health functional foods, and probiotics (e.g., Beztomin). Directly comparable to Kwang Dong's OTC and health functional food offerings and pharmacy-led distribution.

TypeDirect peer
Description

Dong Wha Pharm is a leading Korean pharmaceutical manufacturer with strong positions in both prescription drugs and traditional Korean medicine products (e.g., Wonbi-tang, Gamcho-tang). Comparable to Kwang Dong in OTC and herbal medicine portfolio and pharmacy distribution.

TypeDirect peer
Description

Boryung Pharmaceutical is a Korean pharma company producing prescription drugs (notably Kanarb) and OTC/consumer health products. Comparable to Kwang Dong in Korean-domestic pharmaceutical manufacturing and pharmacy-channel distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment4 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kwang Dong Pharmaceutical

Consumer Pharmaceuticals and Health Functional Foodsekdp.com

Kwang Dong Pharmaceutical is a South Korean pharmaceutical company founded in 1963 that manufactures traditional herbal tonics, prescription drugs, OTC medicines, health functional foods, and consumer beverages (notably Vita500), distributing them through pharmacies, convenience stores, supermarkets, and proprietary e-commerce platforms.

What Kwang Dong Pharmaceutical does

Kwang Dong Pharmaceutical (광동제약) is a South Korean pharmaceutical and consumer health company headquartered in Gwangmyeong-si, Gyeonggi-do, founded in 1963. The company operates across four primary revenue streams: ethical/prescription pharmaceuticals (including diabetes medications such as 다콤시타정 and 피오맥스정), over-the-counter general pharmaceuticals (including the founding product 경옥고/Kyung-ok-go and 아이톡 eye drops), health functional foods (vitamins, supplements, and ginseng-based products), and general distribution beverages and foods (Vita500, Sunkist-licensed drinks, 옥수수수염차, 헛개차). Its flagship consumer brand, 비타500 (Vita500), launched in 2001 as Korea's first vitamin C-containing drink, has cumulatively surpassed 25 billion bottles sold by 2010 and reached a run-rate of 40 million bottles per month by 2012.

The company's product portfolio is anchored in traditional Korean herbal medicine formulations documented in the 17th-century classical text Donguibogam (동의보감), combined with modern pharmaceutical and beverage manufacturing under HACCP and GMP dual certification. Its founding product, 경옥고 (Kyung-ok-go), is a herbal tonic made from ginseng, poria, raw rehmannia, and honey, slow-cooked at 98°C for 120 hours, and is sold exclusively through pharmacies as a licensed general pharmaceutical. Vita500 and its derivatives (Vita500 ZERO, ZERO Sparkling, Kids, Sports C, ACE, Gold) provide differentiated vitamin C delivery formats. The company holds Korean Patent No. 10-2020-0069921 for a composite antler-angelica gigas extract used in 노녹용전력선보감, marketed as Korea's first and only antler-based health functional food as of November 2024. ISMS information security certification covers external service channels through April 2027.

Kwang Dong runs a hybrid B2C/B2B distribution model with channels tailored to product category: prescription ethical drugs and 경옥고 through pharmacy networks nationwide; general distribution beverages (Vita500, Sunkist, 옥수수수염차) through convenience stores and supermarkets; and direct-to-consumer sales through three company-operated e-commerce platforms—광동상회 (kwangdongmart.com), KD케어몰 (kdcaremall.com), and 광동약국몰 (kdshop.co.kr). Marketing relies on mass media (TV, radio, print), celebrity endorsements (Karina, Jeon So-mi, Baek Jong-won, Yu Hae-jin), and social media. The company is publicly listed with a dual co-CEO governance structure introduced in March 2026 (Choi Seong-won as Vision CEO, Park Sang-young as Management CEO) and wholly-owned subsidiaries spanning e-commerce (Kwangdong Mart, KD Care Mall), health bio (Kwang Dong Health Bio), and distribution (Kwang Dong Life Health).

Kwang Dong Pharmaceutical firmographics

Firmographics
Name
Kwang Dong Pharmaceutical
Legal name
Kwang Dong Pharmaceutical Co., Ltd.
Website
https://ekdp.com
Company type
Public
Founded year
1963
Operating status
Operating
Headcount range
51–100 employees
Short description
Kwang Dong Pharmaceutical is a South Korean pharmaceutical company founded in 1963 that manufactures traditional herbal tonics, prescription drugs, OTC medicines, health functional foods, and consumer beverages (notably Vita500), distributing them through pharmacies, convenience stores, supermarkets, and proprietary e-commerce platforms.
Ownership category
akta.pro rank

Kwang Dong Pharmaceutical industry classification

Industry
Product category
Consumer Pharmaceuticals and Health Functional Foods
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYCRADAHAN
Powdered & Instant Beverage Mixes (Drink Mixes, Instant Coffee/Tea, Electrolytes)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Non-Alcoholic Beverages (Coffee, Tea, Soft Drinks, Water)
SECONDARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAGAB
Vitamins & Minerals (Single Nutrients)
SECONDARYCRAOAHAG
Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience)

Keywords

  • Consumer pharmaceuticals
  • Korean herbal medicine
  • Vitamin C beverages
  • Health functional foods
  • OTC medicines

Where Kwang Dong Pharmaceutical is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

Kwang Dong Pharmaceutical business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D

Revenue model

  1. Ethical/Prescription Pharmaceuticals: Prescription drugs requiring physician prescriptions, including medications for diabetes (경구용 혈당강하제), cardiovascular conditions, and other therapeutic categories.
  2. General Pharmaceuticals (OTC): Over-the-counter medicines sold directly to consumers through pharmacies, including products like 경옥고, 아이톡 eye drops, and various cold/flu remedies.
  3. Health Functional Foods: Products with functional health claims including vitamins, supplements, and ginseng-based products regulated under Korea's Health Functional Food Act.
  4. General Distribution Foods: Beverages and food products distributed through convenience stores, supermarkets, and general retail channels. Includes 비타500, 썬키스트, traditional herbal beverages, and various drink products.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Kwang Dong Pharmaceutical product offering

Product offering

Core offering

Kwang Dong Pharmaceutical manufactures and sells a diversified portfolio of prescription pharmaceuticals, OTC medicines, health functional foods, traditional Korean herbal tonics, and consumer beverages under brands such as Vita500 (비타500), Kyung-ok-go (경옥고), Sunkist, Corn silk tea, Hutgae-cha, Carmex, and Gongjindan. The company operates HACCP- and GMP-certified production facilities and distributes products through pharmacies, convenience stores, supermarkets, and company-owned e-commerce platforms (kwangdongmart.com, kdcaremall.com, kdshop.co.kr) primarily in South Korea with select export to Japan.

Product overview

Kwang Dong Pharmaceutical is a comprehensive pharmaceutical and health products company offering a diverse portfolio organized into: general pharmaceuticals (일반의약품), prescription drugs (전문의약품), raw material pharmaceuticals, quasi-drugs, pharmacy drinks, general food products, health functional foods, and traditional Korean herbal products. Key brands include 비타500 (flagship vitamin C drink launched 2001, Korea's first vitamin drink), 경옥고 (founding product since 1963, traditional herbal tonic), 헛개차, 옥수수수염차, 광동초이스 ( 쌍화진 series), 카멕스 (lip care), 썬키스트 (citrus beverages), 레돌민 (sleep aid), and various health supplements. The company also offers prescription medications for diabetes treatment (다콤시타정, 디아리드정, 피오맥스정). The portfolio spans from traditional Korean medicine to modern functional beverages and health supplements, addressing various health needs from fatigue recovery to immune support.

Differentiator

Problem solved

Functional benefit

Brands

  • 비타500 (Vita500): Healthy vitamin C drink containing 500mg of vitamin C, the company's flagship consumer health beverage.
  • 경옥고 (Kyung-ok-go)
  • 광동 초이스 (Kwangdong Choice)
  • 썬키스트 (Sunkist)
  • 옥수수수역차
  • 헛개차
  • 카멕스 (Carmex)

Products and services

  • Vita500 (비타500) Korea's first vitamin-containing drink containing 500mg of vitamin C; the flagship consumer health beverage available in multiple variants. Targets health-conscious consumers, students, and general public seeking daily vitamin C intake and energy support.
  • Kyung-ok-go (경옥고) Traditional Korean herbal tonic (일반의약품) based on a prescription from Donguibogam; made by simmering ginseng, poria, raw rehmannia, and honey for 120 hours (5 days). Targets health-conscious consumers seeking fatigue recovery, vitality, and traditional wellness support. Sold in stick pack format since 2016.
  • Vita500 ZERO (비타500 ZERO) Zero-sugar, zero-calorie version of Vita500 containing 500mg vitamin C. Targets consumers seeking sugar-free vitamin supplementation.
  • Vita500 ZERO Sparkling (비타500 ZERO 스파클링) Sparkling water version of Vita500 ZERO launched in 2024. Targets consumers seeking carbonated, zero-sugar vitamin C beverages.
  • Corn Silk Tea (옥수수수염차) Traditional herbal tea product for health maintenance. Distributed through convenience stores, supermarkets, and company e-commerce channels.
  • Hutgae-cha (헛개차) Traditional herbal tea made from Houttuynia cordata; distributed through convenience stores and supermarkets.
  • Sunkist (썬키스트) Licensed Sunkist brand beverage products including Sunkist Orange Soda and Sunkist Coco (coconut jelly drink). Distributed through convenience stores and supermarkets.
  • Carmex (카멕스) Lip balm and lip care products; consumer personal care offering for everyday lip moisture and protection.
  • Eyetok (아이톡) Eye drop products including 아이톡점안액 (Eyetok trehalose-hydrate eye drops) for eye moisture and lubrication. Sold through pharmacies as OTC general pharmaceutical.
  • Redormin (레돌민) Sleep aid product (general pharmaceutical, sedative class). Sold through pharmacies. Targets consumers with sleep difficulties.
  • Gongjindan (공진단) Traditional Korean medicine tonic (general pharmaceutical, tonic/restorative class). Sold through pharmacies for vitality and recovery.
  • Kwangdong Chimhwan (광동 침향환) Traditional herbal pill (환/丸) containing aromatic resin (침향), honey, deer antler, and various Korean medicinal herbs. Classified as traditional material food (전통소재식품).
  • Kwangdong Health Functional Foods Line Health functional foods including Kwangdong Multi Vitamin Mineral, Kwangdong Eye Health Lutein, Kwangdong Green Propolis, Kwangdong Lutein Calcium, Kwangdong Bright 365 Red Ginseng, and antler-based products (including patented 녹용전립선보감). Sold through pharmacies and retail channels.
  • Kwangdong General Pharmaceuticals Line General OTC pharmaceuticals including Kwangdong Ssanghwatang, Kwangdong Wonhwatang, Kwangdong Uhwangcheongsimwon, Multi Capsule F, Hadicof-F, and various vitamins and digestive aids. Sold through pharmacies.
  • Kwangdong Prescription Pharmaceuticals Line Prescription pharmaceuticals (전문의약품) including 다콤시타정, 디아리드정, 자누로디정, and 피오맥스정 for diabetes treatment. Sold through pharmacies upon physician prescription.
  • Vita500 Kids (비타500 키즈) Product line extension of Vita500 formulated for children; vitamin C beverage for pediatric consumers.
  • Vita500 Sports C (비타500 스포츠 C) Product line extension of Vita500 formulated for athletes and active individuals; vitamin C beverage for sports/recovery use.

Quantifiable outcome

  • Liquid vitamin C absorption is approximately 2x higher than capsule or tablet forms based on clinical study (Journal of Food Science, 2022)
  • +1 more outcomes

Companies that use Kwang Dong Pharmaceutical

Customer profile

Segments3 records

Ideal customer profiles4 records

Kwang Dong Pharmaceutical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Kwang Dong Pharmaceutical partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Precision Bio (프리시전바이오)coreStrategic or Co-development Partner · 1 January 2026Kwang Dong Pharmaceutical participated in Precision Bio's capital increase in October 2025, indicating a strategic investment in the biotechnology sector. This aligns with the company's expansion into precision medicine and advanced healthcare solutions.
  • Kwang Dong Health Bio (광동헬스바이오)coreStrategic or Co-development Partner · 1 January 2026Kwang Dong Pharmaceutical participates in Kwang Dong Health Bio's capital increases and provides funding support, indicating this subsidiary is a core part of the company's health and biotechnology strategy. Products like 녹용전립선보감 are manufactured at the Kwang Dong Health Bio factory.
  • Kwang Dong Life Health (광동생활건강)coreChannel Partner/ Reseller/ DistributorFamily company handling distribution and sales of health and lifestyle products. Listed as the seller/distributor for various health functional foods and beauty products. Approved for concurrent representation as CEO of the company.
  • Kwang Dong Hospital (광동병원)minorChannel Partner/ Reseller/ DistributorFamily company hospital operation, part of the Kwang Dong group ecosystem. Serves as a related business entity within the corporate family.
  • Korea B2B Platform (코리아이플랫폼)minorChannel Partner/ Reseller/ DistributorB2B e-commerce platform (koreab2b.com) operated by the company for business-to-business product distribution.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Kwang Dong Pharmaceutical competitors and assessment

Company assessment

Broad incumbents

  • Bayer Consumer Health: Bayer Consumer Health produces global vitamin and supplement brands (Redoxon, Berocca, Supradyn) that overlap with Kwang Dong's vitamin C drink and health functional food portfolio. Broad incumbent in the same OTC vitamin category with multinational scale advantages.

Direct peers

  • Dong-A Pharmaceutical: Dong-A Pharmaceutical is a major Korean pharmaceutical company with both prescription drugs (e.g., Stillen) and OTC consumer health brands (e.g., Bacchus, Wonmi). It directly competes with Kwang Dong across OTC and consumer beverage categories in the Korean market.
  • Korea Ginseng Corporation: Korea Ginseng Corporation (KGC) is the state-affiliated producer of Cheong-Kwan-Jang red ginseng products, directly competing with Kwang Dong's herbal tonic (Kyung-ok-go) and ginseng-based health functional foods in the Korean traditional wellness category.
  • Yuhan Corporation: Yuhan Corporation is a major Korean pharmaceutical and consumer health company producing prescription drugs and OTC products. Comparable to Kwang Dong in scale, listed-company structure, and diversified pharma/consumer health portfolio.
  • Binggrae: Binggrae is a major Korean food and beverage company producing mass-market drinks and snacks distributed through Korean convenience stores and supermarkets. Directly comparable to Kwang Dong's general distribution foods and Vita500/Sunkist beverage portfolio in retail channels.
  • Ildong Pharmaceutical: Ildong Pharmaceutical is a Korean pharmaceutical company with a portfolio spanning prescription drugs, OTC, health functional foods, and probiotics (e.g., Beztomin). Directly comparable to Kwang Dong's OTC and health functional food offerings and pharmacy-led distribution.
  • Dong Wha Pharm: Dong Wha Pharm is a leading Korean pharmaceutical manufacturer with strong positions in both prescription drugs and traditional Korean medicine products (e.g., Wonbi-tang, Gamcho-tang). Comparable to Kwang Dong in OTC and herbal medicine portfolio and pharmacy distribution.
  • Boryung Pharmaceutical: Boryung Pharmaceutical is a Korean pharma company producing prescription drugs (notably Kanarb) and OTC/consumer health products. Comparable to Kwang Dong in Korean-domestic pharmaceutical manufacturing and pharmacy-channel distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Kwang Dong Pharmaceutical social profiles

Digital presence

Kwang Dong Pharmaceutical compliance and trust

Trust signal

Compliance3 records

Kwang Dong Pharmaceutical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kwang Dong Pharmaceutical leadership team

Management profile

Number of profiles

Profiles6 records

Kwang Dong Pharmaceutical subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Kwang Dong Pharmaceutical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kwang Dong Pharmaceutical M&A and investment

M&A and investment

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kwang Dong Pharmaceutical

What does Kwang Dong Pharmaceutical do?

Kwang Dong Pharmaceutical manufactures and sells a diversified portfolio of prescription pharmaceuticals, OTC medicines, health functional foods, traditional Korean herbal tonics, and consumer beverages under brands such as Vita500 (비타500), Kyung-ok-go (경옥고), Sunkist, Corn silk tea, Hutgae-cha, Carmex, and Gongjindan. The company operates HACCP- and GMP-certified production facilities and distributes products through pharmacies, convenience stores, supermarkets, and company-owned e-commerce platforms (kwangdongmart.com, kdcaremall.com, kdshop.co.kr) primarily in South Korea with select export to Japan.

Is Kwang Dong Pharmaceutical a public or private company?

Kwang Dong Pharmaceutical is a public company. It is classified as public and is currently operating.

When was Kwang Dong Pharmaceutical founded?

Kwang Dong Pharmaceutical was founded in 1963. It employs 51 to 100 people.

Where is Kwang Dong Pharmaceutical based?

Kwang Dong Pharmaceutical is headquartered in Seoul, South Korea, in the Asia region.

How does Kwang Dong Pharmaceutical make money?

Four revenue lines are on record. Ethical/Prescription Pharmaceuticals are the primary driver. The others are general Pharmaceuticals (OTC), health Functional Foods and general Distribution Foods.

Who are Kwang Dong Pharmaceutical's main competitors?

Bayer Consumer Health is listed as a broad incumbent. Direct peers are Dong-A Pharmaceutical, Korea Ginseng Corporation, Yuhan Corporation, Binggrae, Ildong Pharmaceutical, Dong Wha Pharm and Boryung Pharmaceutical.

Does Kwang Dong Pharmaceutical have an API?

No public API is recorded for Kwang Dong Pharmaceutical.

What industry is Kwang Dong Pharmaceutical in?

Kwang Dong Pharmaceutical's product category is Consumer Pharmaceuticals and Health Functional Foods. Its primary akta.pro industry code is CRADAHAN, Powdered & Instant Beverage Mixes (Drink Mixes, Instant Coffee/Tea, Electrolytes), with a secondary code of CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges). Its NAICS code is 3254 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NaverFrom aespa to AKMU, pharmaceuticals tap K-pop star power to court younger consumersPharmaceutical companies are using K-pop stars to market products to younger consumers, including JW Pharmaceutical's eye drops and makeup remover, Kwangdong's Vita 500, and GC Biopharma's Zenol. The campaigns aim to broaden customer bases and extend product experiences through personalized packaging and limited-edition items.EIN PresswireKwangdong Pharmaceutical Marks 63rd Anniversary, Vows New Leap ForwardKwangdong Pharmaceutical marked its 63rd anniversary on the 19th, holding a ceremony with executives and employees. The company pledged to strengthen pharmaceutical expertise and financial soundness for sustainable growth, and awards were given to about 160 recipients.BusinesskoreaKwangdong Pharmaceutical's 'Vita500 Ion Kick' will be the official partner of pickleball until 2027.Kwangdong Pharmaceutical announced on the 25th that it signed a sponsorship agreement with the Korea Pickleball Association to support related competitions, promoting its Vita500 Ion Kick product. The company will first sponsor the 2026 KPA President's Cup in Oak Valley, Wonju, from the 27th to the 30th, with branded MVP and performance awards. The deal runs through 2027.SportschosunFrom Corn Silk Tea to Barley and Chicory Roasted Drinks: Alternative Coffee Market Grows as 'Caffeine Free' Trend SpreadsThe alternative coffee market in South Korea is expanding rapidly as consumers shift toward caffeine-free beverages to address health concerns and embrace self-care lifestyles. Major companies including Kwangdong Pharmaceutical, TEAZEN, and Lotte Mart are launching new products such as corn silk tea, barley-based substitutes, and chicory blends to capture this growing demand.NateKwangdong Pharmaceutical builds 'smart ecological factory'...reducing greenhouse gases by 600 tons annually: Nate NewsKwangdong Pharmaceutical has been selected for Korea's 2026 Smart Eco-Factory Construction Project and will build facilities equipped with energy-saving boilers, waste heat recovery systems, and ICT-based monitoring to reduce annual greenhouse gas emissions by approximately 600 tons and waste generation by about 16 tons. The project is expected to generate annual energy cost savings of around 200 million won while enhancing the company's manufacturing cost competitiveness. Kwangdong Pharmaceutical recently published its first sustainability management report and established an ESG committee under its board of directors.ChosunbizKwangdong pivots to pharma but weak R&D and governance drag profitKwangdong Pharmaceutical reported 1.6595 trillion won in consolidated revenue last year but posted only 31 billion won in operating profit, yielding a thin 1.9% operating margin compared to domestic peers Daewoong Pharmaceutical (12.5%), Hanmi Pharmaceutical (16.7%), and GC Biopharma (3.5%), largely because external in-licensed products accounted for approximately 70% of total revenue. The company is attempting to restructure toward a specialized drugmaker by pursuing a license-in strategy in ophthalmology and rare diseases, creating a future innovation team and contributing to biotech investment funds, but its R&D spending has remained at just 1%–2% of revenue and no significant in-house new drug pipeline has emerged since the KD-101 phase 2a trial in 2020. Governance concerns are compounding investor skepticism, including a withdrawn exchangeable bond issuance, pledged shares used as collateral for loans, the chairman receiving 1.269 billion won in compensation, and a share price that has fallen from a 52-week high of 12,800 won to the 6,000-won range, prompting criticism on stock forums.Aju PressKwangdong Pharmaceutical Introduces 'Ethics Day' to Strengthen Compliance ManagementKwangdong Pharmaceutical has established an 'Ethics Day' and elevated its Anti-Corruption Subcommittee to a Compliance Committee to strengthen its compliance management system. On June 2, the company held a ceremony to award the committee's charter and appointed compliance officers while conducting training for internal auditors. The company obtained integrated certification for ISO 37001 (Anti-Corruption Management System) and ISO 37301 (Compliance Management System) in 2023.MarketScreenerUS Pharmatech Inc. announced that it expects to receive $3.4037 million in funding from Kwangdong Healthbio Co., Ltd.US Pharmatech Inc. announced it will receive $3,403,700 in funding from Kwangdong Healthbio Co., Ltd. through a convertible bond issuance, with the transaction expected to close on January 6, 2026. The bonds carry a fixed conversion price of KRW 7,241 per share and are 100% convertible, with conversion available from November 1, 2029 to December 31, 2029. The bonds will mature on January 6, 2030.ChosunbizJeju Samdasoo Renews Four-Year Distribution Deal with Kwangdong PharmaceuticalJeju Development Corporation signed a four-year distribution contract with Kwangdong Pharmaceutical for Jeju Samdasoo, effective 2026, covering all domestic regions except Jeju. The bottled water holds a 40% domestic market share. The deal aims to meet changing consumer demands.GlobeNewswireOcugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in KoreaOcugen and Kwangdong signed a licensing agreement for OCU400, a gene therapy for retinitis pigmentosa, granting Kwangdong exclusive Korean rights. The deal includes upfront fees up to $7.5 million, sales milestones, and 25% royalties on net sales. Ocugen plans a Phase 3 trial and a U.S. BLA filing in 2026.